Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Letter to the Editor

Focus on MRSA/SA SSTI Assay Failure in Prosthetic Joint Infections: 213 Consecutive Patients Later

Marie Titécat, Frédéric Wallet, Olivier Robineau, Michel Valette, Henri Migaud, Eric Senneville, Caroline Loïez
Robin Patel, Editor
Marie Titécat
aInstitute of Microbiology, Lille University Hospital, Lille, France
eUniversity of Lille, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frédéric Wallet
aInstitute of Microbiology, Lille University Hospital, Lille, France
eUniversity of Lille, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Robineau
bUniversity Department of Infectious Diseases, Gustave Dron Hospital, Tourcoing, France
eUniversity of Lille, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Valette
bUniversity Department of Infectious Diseases, Gustave Dron Hospital, Tourcoing, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henri Migaud
cOrthopaedic Department, Lille University Hospital, Lille, France
dNorthwest Reference Center for Osteoarticular Infections (CRIOAC-G4 Lille-Tourcoing), Lille, France
eUniversity of Lille, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Senneville
bUniversity Department of Infectious Diseases, Gustave Dron Hospital, Tourcoing, France
dNorthwest Reference Center for Osteoarticular Infections (CRIOAC-G4 Lille-Tourcoing), Lille, France
eUniversity of Lille, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Loïez
aInstitute of Microbiology, Lille University Hospital, Lille, France
eUniversity of Lille, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robin Patel
Mayo Clinic
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.01658-16
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

LETTER

In prosthetic joint infection (PJI) cases (1), rapid detection of methicillin-resistant staphylococci (MRS) is the key to avoiding the use of broad-spectrum antimicrobials such as vancomycin. Indeed, vancomycin use is associated with a risk of renal impairment, a lesser efficacy against methicillin-susceptible strains compared with beta-lactams (2), and a negative ecological impact. In these regards, the Xpert MRSA/SA SSTI assay (Cepheid, Sunnyvale, CA, USA) appears as a potentially useful tool. It enables the detection of the genetic support of methicillin resistance, the mecA gene, directly in intraoperative samples (IOS) in less than 1 h (3). In our center, the test has been routinely used for the last 4 years in order to stop the anti-MRS antibiotic early in those patients managed for PJI and having a negative result for the detection of the mecA gene in surgical samples. For each patient, three IOS were taken to perform both standard culture and molecular testing before any antimicrobial therapy. These three samples were also kept for prolonged culture (15 days) in Rosenow's enrichment broth (4, 5). The criteria for a microbiological infection were the same coagulase-negative Staphylococcus (CoNS) species related to the same antimicrobial pattern found in culture in at least two samples and/or an S. aureus strain found in culture in at least one sample. Methicillin susceptibility was assessed by using Vitek2 AST cards (bioMérieux, Marcy l'Etoile, France). Oxacillin and cefoxitin results issued from the automated system were interpreted according to the Comité de l'antibiogramme de la Société Française de Microbiologie recommendations (http://www.sfm-microbiologie.org ). A cefoxitin disk was also used in the case of a discrepancy.

Among the 213 consecutive patients studied (118 with hip, 82 with knee, and 13 with shoulder prostheses), culture was correlated with the molecular detection of MRS in 186 cases (87.3%). The overall sensitivity (Se), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) were 56, 93, 58, and 92%, respectively. Xpert failed to detect a resistant strain in 14 (6.6%) of 213 patients who were examined carefully owing to a high risk of clinical failure. Eight of these false-negative patients were positive for a single methicillin-resistant (MR) coagulase-negative Staphylococcus (MRCoNS) strain, in either standard or enriched medium, which could be considered contamination. The six remaining cases were positive by culture for an MRCoNS strain (patients 1 to 5) or MRSA (methicillin-resistant Staphylococcus aureus) (patient 6) PJI (Table 1). Xpert failed to diagnose one patient (patient 1) because of late amplification (cycle threshold [CT], 39.1) interpreted as negative by the software. Two other patients (no. 3 and 5) had polymicrobial infections. Patients 2, 4, and 6 were infected with MRSE (MR Staphylococcus epidermidis) and MRSA small-colony variants, respectively. None of these false-negative patients had a microbiological relapse. In the light of these data, the sensitivity, specificity, PPV, and NPV moved to 75, 93, 58, and 97%, respectively.

View this table:
  • View inline
  • View popup
TABLE 1

Characteristics of six patients negative for mecA detection

Xpert is an easy-to-use PCR method that has been turned away from in favor of bone and joint infection diagnosis and rapid antimicrobial adjustment. High performance of the test was described in osteoarticular infections (3) and chronic PJI (5), but this was recently outweighed by poor sensitivity results (36%) in cases of MRCoNS infection (6). These points were examined here in an extended cohort of 213 patients. A focus on false-negative cases revealed different kinds of risk factors, such as (i) MRCoNS infections, (ii) a high CT value related to a low inoculum concentration, (iii) polymicrobial infections, and (iv) small-colony variant infections. Furthermore, a comparison of PCR and culture results was made, but culture remains an imperfect gold standard that must be interpreted according to the patient's medical history (e.g., 8/14 contaminations).

In conclusion, our results confirm the high NPV of Xpert, which makes it a useful tool in an attempt to reduce vancomycin use in PJI.

ACKNOWLEDGMENTS

We thank Philippe Choisy for technical assistance and P. R. Mecos for critically reading the manuscript.

E. Senneville is a speaker for Cepheid. All of the other authors have no conflicts of interest to disclose.

  • Copyright © 2017 American Society for Microbiology.

All Rights Reserved .

REFERENCES

  1. 1.↵
    1. Zimmerli W,
    2. Trampuz A,
    3. Ochsner PE
    . 2004. Prosthetic-joint infections. N Engl J Med351:1645–1654. doi:10.1056/NEJMra040181.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Kim SH,
    2. Kim KH,
    3. Kim HB,
    4. Kim NJ,
    5. Kim EC,
    6. Oh M,
    7. Choe KW
    . 2008. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother52:192–197. doi:10.1128/AAC.00700-07.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Dubouix-Bourandy A,
    2. de Ladoucette A,
    3. Pietri V,
    4. Mehdi N,
    5. Benzaquen D,
    6. Guinand R,
    7. Gandois JM
    . 2011. Direct detection of Staphylococcus osteoarticular infections by use of Xpert MRSA/SA SSTI real-time PCR. J Clin Microbiol49:4225–4230. doi:10.1128/JCM.00334-11.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Senneville E,
    2. Savage C,
    3. Nallet I,
    4. Yazdanpanah Y,
    5. Giraud F,
    6. Migaud H,
    7. Dubreuil L,
    8. Courcol R,
    9. Mouton Y
    . 2006. Improved aero-anaerobe recovery from infected prosthetic joint samples taken from 72 patients and collected intraoperatively in Rosenow's broth. Acta Orthop77:120–124. doi:10.1080/17453670610045795.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Titécat M,
    2. Loïez C,
    3. Senneville E,
    4. Wallet F,
    5. Dezèque H,
    6. Legout L,
    7. Migaud H,
    8. Courcol RJ
    . 2012. Evaluation of rapid mecA gene detection versus standard culture in staphylococcal chronic prosthetic joint infections. Diagn Microbiol Infect Dis73:318–321. doi:10.1016/j.diagmicrobio.2012.04.011.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Lourtet-Hascoëtt J,
    2. Bicart-See A,
    3. Félicé MP,
    4. Giordano G,
    5. Bonnet E
    . 2015. Is Xpert MRSA/SA SSTI real-time PCR a reliable tool for fast detection of methicillin-resistant coagulase-negative staphylococci in periprosthetic joint infections?Diagn Microbiol Infect Dis83:59–62. doi:10.1016/j.diagmicrobio.2015.04.009.
    OpenUrlCrossRef
PreviousNext
Back to top
Download PDF
Citation Tools
Focus on MRSA/SA SSTI Assay Failure in Prosthetic Joint Infections: 213 Consecutive Patients Later
Marie Titécat, Frédéric Wallet, Olivier Robineau, Michel Valette, Henri Migaud, Eric Senneville, Caroline Loïez
Journal of Clinical Microbiology Jan 2017, 55 (2) 635-637; DOI: 10.1128/JCM.01658-16

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Focus on MRSA/SA SSTI Assay Failure in Prosthetic Joint Infections: 213 Consecutive Patients Later
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Focus on MRSA/SA SSTI Assay Failure in Prosthetic Joint Infections: 213 Consecutive Patients Later
Marie Titécat, Frédéric Wallet, Olivier Robineau, Michel Valette, Henri Migaud, Eric Senneville, Caroline Loïez
Journal of Clinical Microbiology Jan 2017, 55 (2) 635-637; DOI: 10.1128/JCM.01658-16
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

prosthetic joint infection
mecA
vancomycin
Staphylococcus
Diagnostic Tests, Routine
methicillin resistance
Molecular Diagnostic Techniques
Osteoarthritis
Prosthesis-Related Infections
Staphylococcal Infections
Staphylococcus

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X